EP3116997
Aðferðir og samsetningar sem tengjast crispr/cas til meðferðar á leber-fráviki 10 (leber’s congenital amaurosis 10, lca10)
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
10.3.2015EP published:
15.5.2019EP application number:
15714320.7
EP translation filed:
14.8.2019Grant published:
15.9.2019EPO information:
European Patent Register
Max expiry date:
9.3.2035Expiry date:
9.3.2025
Title:
CRISPR/CAS-RELATED METHODS AND COMPOSITIONS FOR TREATING LEBER'S CONGENITAL AMAUROSIS 10 (LCA10)
Timeline
Today
10.3.2015EP application
15.5.2019EP Publication
14.8.2019Translation submitted
15.9.2019Registration published
9.3.2025Expires
Owner
Name:
Editas Medicine, Inc.Address:
11 Hurley Street, 02141, Cambridge, MA, US
Inventor
Name:
MAEDER, Morgan, L.Address:
Jamaica Pllain, MA, US
Name:
BUMCROT, David, A.Address:
Belmont, MA, US
Name:
SHEN, ShenAddress:
Watertown, MA, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201461950733 PDate:
10.3.2014Country:
US
Number:
201462036576 PDate:
12.8.2014Country:
US
Classification
Categories:
C12N 15/113, A61K 31/7088, C12N 9/22, C12N 15/86, A61K 48/00
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 13.2.2020
Expires: 9.3.2021
Payer: Árnason Faktor ehf.
Number: 7
Paid: 18.2.2021
Expires: 9.3.2022
Payer: Sigurjónsson & Thor ehf.
Number: 8
Paid: 18.2.2022
Expires: 9.3.2023
Payer: Patice ehf.
Number: 9
Paid: 20.2.2023
Expires: 9.3.2024
Payer: Árnason Faktor ehf.
Number: 10
Paid: 28.2.2024
Expires: 9.3.2025
Payer: Árnason Faktor ehf.